NEW HAVEN, Conn.--(BUSINESS WIRE)--Yale University and the National Foundation for Cancer Research (NFCR) announced the establishment of an NFCR Center for Anti-Cancer Drug Design and Discovery to develop new beta-peptide inhibitors that will play critical roles in the fight against many types of cancer.
